These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1800400)

  • 61. End-stage renal disease in Canada: prevalence projections to 2005.
    Schaubel DE; Morrison HI; Desmeules M; Parsons DA; Fenton SS
    CMAJ; 1999 Jun; 160(11):1557-63. PubMed ID: 10373996
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Future evolution of the ESRD patient population--a perspective for the year 2000.
    Molzahn M
    Nephrol Dial Transplant; 1996; 11 Suppl 8():59-62. PubMed ID: 9044343
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pattern of end stage renal disease in a tertiary care center.
    Khakurel S; Agrawal RK; Hada R
    JNMA J Nepal Med Assoc; 2009; 48(174):126-30. PubMed ID: 20387352
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Trends in treatment and outcomes of survival of adolescents initiating end-stage renal disease care in the United States of America.
    Ferris ME; Gipson DS; Kimmel PL; Eggers PW
    Pediatr Nephrol; 2006 Jul; 21(7):1020-6. PubMed ID: 16773416
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Recent statistics of renal transplantation: treatment of end stage renal disease--comparison between the western world and Japan].
    Ishikawa I
    Nihon Jinzo Gakkai Shi; 2004 Jan; 46(1):12-9. PubMed ID: 15007906
    [No Abstract]   [Full Text] [Related]  

  • 66. Outcome of pediatric patients with end-stage renal disease in Switzerland 1973-1982.
    Leumann EP; Egli F; Fanconi A; Guignard JP; Koegel R; Oetliker O; Paunier L
    Int J Pediatr Nephrol; 1984 Sep; 5(3):155-8. PubMed ID: 6500810
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Chronic renal failure].
    Arai J; Kubo K; Sugino N
    Nihon Rinsho; 1993 Jan; 51 Suppl():397-408. PubMed ID: 8459569
    [No Abstract]   [Full Text] [Related]  

  • 68. Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States.
    Kitiyakara C; Eggers P; Kopp JB
    Am J Kidney Dis; 2004 Nov; 44(5):815-25. PubMed ID: 15492947
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Incidence, prevalence and mortality trends of dialysis end-stage renal disease in Taiwan from 1990 to 2001: the impact of national health insurance.
    Yang WC; Hwang SJ;
    Nephrol Dial Transplant; 2008 Dec; 23(12):3977-82. PubMed ID: 18628366
    [TBL] [Abstract][Full Text] [Related]  

  • 70. End-stage renal disease in sub-Saharan and South Africa.
    Naicker S
    Kidney Int Suppl; 2003 Feb; (83):S119-22. PubMed ID: 12864889
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Maintenance dialysis population dynamics: current trends and long-term implications.
    Lysaght MJ
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S37-40. PubMed ID: 11792760
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Time trends in the epidemiology of renal transplant patients with type 1 diabetes mellitus over the last four decades.
    Cao C; Hellermann JP; Weber M; Ambühl PM
    Nephrol Dial Transplant; 2006 Mar; 21(3):770-5. PubMed ID: 16401627
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Ten-year experience in renal replacement therapy in children. A report from Dialysis Center, Department of Pediatric Nephrology, Children's University Hospital in Lublin].
    Zajaczkowska M; Kołłataj B; Bieniaś B; Wieczorkiewicz-Płaza A; Borzecka H; Sikora P; Majewski M
    Przegl Lek; 2006; 63 Suppl 3():162-5. PubMed ID: 16898520
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Geographic, ethnic, age-related and temporal variation in the incidence of end-stage renal disease in Europe, Canada and the Asia-Pacific region, 1998-2002.
    ; Stewart JH; McCredie MR; Williams SM
    Nephrol Dial Transplant; 2006 Aug; 21(8):2178-83. PubMed ID: 16595584
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Renal outcomes in chronic kidney disease.
    Iseki K
    Nephrology (Carlton); 2010 Jun; 15 Suppl 2():27-30. PubMed ID: 20586944
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The organization and financing of end-stage renal disease treatment in Japan.
    Fukuhara S; Yamazaki C; Hayashino Y; Higashi T; Eichleay MA; Akiba T; Akizawa T; Saito A; Port FK; Kurokawa K
    Int J Health Care Finance Econ; 2007 Sep; 7(2-3):217-31. PubMed ID: 17690980
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Risk of Infective Endocarditis in Patients with End Stage Renal Disease.
    Chaudry MS; Carlson N; Gislason GH; Kamper AL; Rix M; Fowler VG; Torp-Pedersen C; Bruun NE
    Clin J Am Soc Nephrol; 2017 Nov; 12(11):1814-1822. PubMed ID: 28974524
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Forecasting the Incidence and Prevalence of Patients with End-Stage Renal Disease in Malaysia up to the Year 2040.
    Bujang MA; Adnan TH; Hashim NH; Mohan K; Kim Liong A; Ahmad G; Bak Leong G; Bavanandan S; Haniff J
    Int J Nephrol; 2017; 2017():2735296. PubMed ID: 28348890
    [No Abstract]   [Full Text] [Related]  

  • 79. Chronic renal failure after transplantation of a nonrenal organ.
    Ojo AO; Held PJ; Port FK; Wolfe RA; Leichtman AB; Young EW; Arndorfer J; Christensen L; Merion RM
    N Engl J Med; 2003 Sep; 349(10):931-40. PubMed ID: 12954741
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The impact of comorbid and sociodemographic factors on access to renal transplantation.
    Gaylin DS; Held PJ; Port FK; Hunsicker LG; Wolfe RA; Kahan BD; Jones CA; Agodoa LY
    JAMA; 1993 Feb; 269(5):603-8. PubMed ID: 8421364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.